- Elagolix, sold
under the
brand name
Orilissa, is a gonadotropin-releasing
hormone antagonist (GnRH antagonist)
medication which is used in the treatment...
-
Unlike most
other GnRH modulators, but
similarly to
elagolix (brand name
Orilissa),
relugolix is a non-peptide, small-molecule
compound and is
orally active...
- 12 (1): 31–35. doi:10.2174/1574884712666170310111125. PMID 28294070. "
Orilissa (elagolix) FDA Label" (PDF). July 24, 2018.
Retrieved July 31, 2018. Cocchetti...
- agonists, GnRH antagonists, such as
degarelix (Firmagon) and
elagolix (
Orilissa), work by
binding to the GnRH
receptor without activating it,
thereby displacing...
- 000
Degarelix Firmagon Prostate cancer Peptide SC 2008 291,000
Elagolix Orilissa Endometriosis;
Uterine fibroids Non-peptide Oral 2018 126,000 Ganirelix...
- 12 (1): 31–35. doi:10.2174/1574884712666170310111125. PMID 28294070. "
Orilissa (elagolix) FDA Label" (PDF). 24 July 2018.
Retrieved 31 July 2018. Cocchetti...
